File: '\\swfile\EmailIn\20250703 134141 Attachment Telescope Innovations Corp. - News Release - Private Placement (LIFE Offering) - June 2025.docx'

- 2 -

LEGAL*68747364.2

LEGAL*68747364.2

NOT FOR DISTRIBUTION IN THE UNITED STATES

TELESCOPE ANNOUNCES PRIVATE PLACEMENT

Vancouver, BC - July 3, 2025 - Telescope Innovations Corp. (CSE:TELI) (OTCQB:TELIF) (FSE:J4U), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries announces that it will conduct a non-brokered private placement (the "Offering") under the Listed Issuer Financing Exemption (as defined below) of up to 20,000,000 common shares of the Company (each, a "Common Share") at a price of $0.25 per Common Share, to raise gross proceeds of up to $5,000,000.

The net proceeds raised from the Offering will be used to improve inventory position to ensure consistent customer deliveries and infrastructure and for general working capital purposes. In addition, the proceeds will enable the Company to speed development of the Self-Driving Laboratory ("SDL") project and increase business development capacity.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), the Offering is being made to purchasers' resident in Canada, except Quebec, as well as certain jurisdictions outside of Canada, pursuant to the listed issuer financing exemption under Part 5A of NI- 45-106 (the "Listed Issuer Financing Exemption"). The securities offered under the Listed Issuer Financing Exemption will not be subject to a hold period in accordance with applicable Canadian securities laws. There will be an offering document related to the Offering that will be accessible under the Company's SEDAR+ profile at www.sedarplus.ca and on the Company's website at www.telescopeinnovations.com. Prospective investors should read this offering document before making an investment decision.

In connection with closing of the Offering, the Company may pay finders' fees to eligible parties who have assisted in introducing subscribers to the Offering. Completion of the Offering remains subject to regulatory approval.

About Telescope Innovations

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The Company builds and deploys new enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company's aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.

On behalf of the Board,

Telescope Innovations Corp.

Henry Dubina, Chief Executive Officer

For additional information, please contact

Jeffrey Sherman, COO

E: jeff@telescopeinn.com

Forward-Looking Information

The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain certain "forward-looking information" under applicable Canadian securities laws. When or if used in this news release, the words "anticipate," "believe," "estimate," "expect." "target", "plan," "forecast," "may," "schedule," and similar words or expressions identify forward-looking information. This forward-looking information may relate to planned project development, exploration programs, the intended use of the proceeds from the Offering and other factors or information.

Forward-looking information is based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information.

The forward-looking information contained in this news release is made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.